Gemigliptin, metformin combo beats monotherapy in T2DM
(HealthDay)—Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 13 in Diabetes, Obesity and Metabolism.
Sep 20, 2016
0
1